68Ga-NY118

N/A

Report date: 2025/11/28 16:58:38

NME

Base Information

Drug Name68Ga-NY118

Drug Alias NameGallium 68-NY11868Ga-NY118

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPositron-emission tomography enhancersFibroblast activation protein alpha binders

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A